|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
The top 10 open-market insider purchases and sales filed at the SEC Friday.
Chelsea insists Northera's FDA filing is on track despite two of three failed phase III studies.
Chelsea Therapeutics CEO Discusses Q3 2010 Results â¿¿ Earnings Call Transcript
Company to Host Conference Call at 4:30 PM ET
Green Mountain Coffee Roasters and Sealy were among stocks poised to move on above-average volume Wednesday.
Several stocks, including Chelsea Therapeutics and L-1 Identity, are poised to move on above-average volume Monday.
Chelsea's drug Northera improved symptoms for patients with a low blood pressure disorder.
Biotech columnist Adam Feuerstein answers readers' questions about drug and health care-related firms.
The BSMRP, a portfolio of biotech and drug stocks chosen by readers of my weekly Mailbag, is down 23% this year.
Chelsea Therapeutics International, Ltd. Q2 2010 Earnings Call Transcript
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.